Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Parathyroid Neoplasms 2Thyroid Neoplasms 1Thyroid Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Kidney Neoplasms 1Hyperparathyroidism, Primary 1Hypercalcemia 1Humoral Hypercalcemia Of Malignancy 1Hodgkin Disease 1Head and Neck Neoplasms 1Endocrine Gland Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

lenvatinib 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Cancer Metastatic × Denosumab × Head & Neck × Clear all
NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown
35 enrolled
EndocrineHead & Neck

Thyroid Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡